目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global transdermal drug delivery market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global transdermal drug delivery market 2018 - 2022 ($ billion)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Analgesics - Market size and forecast 2023-2028
Exhibit 34: Chart on Analgesics - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Analgesics - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
6.4 Neurological disorders - Market size and forecast 2023-2028
Exhibit 38: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%)
6.5 Hormone replacement therapy - Market size and forecast 2023-2028
Exhibit 42: Chart on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
6.6 Cardiovascular disorders - Market size and forecast 2023-2028
Exhibit 46: Chart on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Application
Exhibit 54: Market opportunity by Application ($ billion)
Exhibit 55: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 56: Chart on Type - Market share 2023-2028 (%)
Exhibit 57: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 58: Chart on Comparison by Type
Exhibit 59: Data Table on Comparison by Type
7.3 Transdermal patches - Market size and forecast 2023-2028
Exhibit 60: Chart on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Transdermal patches - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Transdermal patches - Year-over-year growth 2023-2028 (%)
7.4 Transdermal semisolids - Market size and forecast 2023-2028
Exhibit 64: Chart on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 68: Market opportunity by Type ($ billion)
Exhibit 69: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share by geography 2023-2028 (%)
Exhibit 72: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 111: Market opportunity by geography ($ billion)
Exhibit 112: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 3M Co.
Exhibit 119: 3M Co. - Overview
Exhibit 120: 3M Co. - Business segments
Exhibit 121: 3M Co. - Key news
Exhibit 122: 3M Co. - Key offerings
Exhibit 123: 3M Co. - Segment focus
12.4 Boehringer Ingelheim International GmbH
Exhibit 124: Boehringer Ingelheim International GmbH - Overview
Exhibit 125: Boehringer Ingelheim International GmbH - Business segments
Exhibit 126: Boehringer Ingelheim International GmbH - Key news
Exhibit 127: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 128: Boehringer Ingelheim International GmbH - Segment focus
12.5 Croda International Plc
Exhibit 129: Croda International Plc - Overview
Exhibit 130: Croda International Plc - Business segments
Exhibit 131: Croda International Plc - Key news
Exhibit 132: Croda International Plc - Key offerings
Exhibit 133: Croda International Plc - Segment focus
12.6 Hisamitsu Pharmaceutical Co. Inc.
Exhibit 134: Hisamitsu Pharmaceutical Co. Inc. - Overview
Exhibit 135: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Exhibit 136: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
12.7 Johnson and Johnson
Exhibit 137: Johnson and Johnson - Overview
Exhibit 138: Johnson and Johnson - Business segments
Exhibit 139: Johnson and Johnson - Key news
Exhibit 140: Johnson and Johnson - Key offerings
Exhibit 141: Johnson and Johnson - Segment focus
12.8 Kindeva Drug Delivery L.P.
Exhibit 142: Kindeva Drug Delivery L.P. - Overview
Exhibit 143: Kindeva Drug Delivery L.P. - Product / Service
Exhibit 144: Kindeva Drug Delivery L.P. - Key news
Exhibit 145: Kindeva Drug Delivery L.P. - Key offerings
12.9 Luye Pharma Group Ltd.
Exhibit 146: Luye Pharma Group Ltd. - Overview
Exhibit 147: Luye Pharma Group Ltd. - Business segments
Exhibit 148: Luye Pharma Group Ltd. - Key offerings
Exhibit 149: Luye Pharma Group Ltd. - Segment focus
12.10 Medherant Ltd.
Exhibit 150: Medherant Ltd. - Overview
Exhibit 151: Medherant Ltd. - Product / Service
Exhibit 152: Medherant Ltd. - Key offerings
12.11 Novartis AG
Exhibit 153: Novartis AG - Overview
Exhibit 154: Novartis AG - Business segments
Exhibit 155: Novartis AG - Key offerings
Exhibit 156: Novartis AG - Segment focus
12.12 ProSolus Inc.
Exhibit 157: ProSolus Inc. - Overview
Exhibit 158: ProSolus Inc. - Product / Service
Exhibit 159: ProSolus Inc. - Key offerings
12.13 Purdue Pharma LP
Exhibit 160: Purdue Pharma LP - Overview
Exhibit 161: Purdue Pharma LP - Product / Service
Exhibit 162: Purdue Pharma LP - Key offerings
12.14 Radius Health Inc.
Exhibit 163: Radius Health Inc. - Overview
Exhibit 164: Radius Health Inc. - Product / Service
Exhibit 165: Radius Health Inc. - Key offerings
12.15 Teikoku Seiyaku Co. Ltd.
Exhibit 166: Teikoku Seiyaku Co. Ltd. - Overview
Exhibit 167: Teikoku Seiyaku Co. Ltd. - Product / Service
Exhibit 168: Teikoku Seiyaku Co. Ltd. - Key offerings
12.16 UCB SA
Exhibit 169: UCB SA - Overview
Exhibit 170: UCB SA - Product / Service
Exhibit 171: UCB SA - Key offerings
12.17 Viatris Inc.
Exhibit 172: Viatris Inc. - Overview
Exhibit 173: Viatris Inc. - Business segments
Exhibit 174: Viatris Inc. - Key news
Exhibit 175: Viatris Inc. - Key offerings
Exhibit 176: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global transdermal drug delivery market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Analgesics - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Analgesics - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Application ($ billion)
Exhibits55: Data Table on Market opportunity by Application ($ billion)
Exhibits56: Chart on Type - Market share 2023-2028 (%)
Exhibits57: Data Table on Type - Market share 2023-2028 (%)
Exhibits58: Chart on Comparison by Type
Exhibits59: Data Table on Comparison by Type
Exhibits60: Chart on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Transdermal patches - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Transdermal patches - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Type ($ billion)
Exhibits69: Data Table on Market opportunity by Type ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share by geography 2023-2028 (%)
Exhibits72: Data Table on Market share by geography 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity by geography ($ billion)
Exhibits112: Data Tables on Market opportunity by geography ($ billion)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: 3M Co. - Overview
Exhibits120: 3M Co. - Business segments
Exhibits121: 3M Co. - Key news
Exhibits122: 3M Co. - Key offerings
Exhibits123: 3M Co. - Segment focus
Exhibits124: Boehringer Ingelheim International GmbH - Overview
Exhibits125: Boehringer Ingelheim International GmbH - Business segments
Exhibits126: Boehringer Ingelheim International GmbH - Key news
Exhibits127: Boehringer Ingelheim International GmbH - Key offerings
Exhibits128: Boehringer Ingelheim International GmbH - Segment focus
Exhibits129: Croda International Plc - Overview
Exhibits130: Croda International Plc - Business segments
Exhibits131: Croda International Plc - Key news
Exhibits132: Croda International Plc - Key offerings
Exhibits133: Croda International Plc - Segment focus
Exhibits134: Hisamitsu Pharmaceutical Co. Inc. - Overview
Exhibits135: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Exhibits136: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
Exhibits137: Johnson and Johnson - Overview
Exhibits138: Johnson and Johnson - Business segments
Exhibits139: Johnson and Johnson - Key news
Exhibits140: Johnson and Johnson - Key offerings
Exhibits141: Johnson and Johnson - Segment focus
Exhibits142: Kindeva Drug Delivery L.P. - Overview
Exhibits143: Kindeva Drug Delivery L.P. - Product / Service
Exhibits144: Kindeva Drug Delivery L.P. - Key news
Exhibits145: Kindeva Drug Delivery L.P. - Key offerings
Exhibits146: Luye Pharma Group Ltd. - Overview
Exhibits147: Luye Pharma Group Ltd. - Business segments
Exhibits148: Luye Pharma Group Ltd. - Key offerings
Exhibits149: Luye Pharma Group Ltd. - Segment focus
Exhibits150: Medherant Ltd. - Overview
Exhibits151: Medherant Ltd. - Product / Service
Exhibits152: Medherant Ltd. - Key offerings
Exhibits153: Novartis AG - Overview
Exhibits154: Novartis AG - Business segments
Exhibits155: Novartis AG - Key offerings
Exhibits156: Novartis AG - Segment focus
Exhibits157: ProSolus Inc. - Overview
Exhibits158: ProSolus Inc. - Product / Service
Exhibits159: ProSolus Inc. - Key offerings
Exhibits160: Purdue Pharma LP - Overview
Exhibits161: Purdue Pharma LP - Product / Service
Exhibits162: Purdue Pharma LP - Key offerings
Exhibits163: Radius Health Inc. - Overview
Exhibits164: Radius Health Inc. - Product / Service
Exhibits165: Radius Health Inc. - Key offerings
Exhibits166: Teikoku Seiyaku Co. Ltd. - Overview
Exhibits167: Teikoku Seiyaku Co. Ltd. - Product / Service
Exhibits168: Teikoku Seiyaku Co. Ltd. - Key offerings
Exhibits169: UCB SA - Overview
Exhibits170: UCB SA - Product / Service
Exhibits171: UCB SA - Key offerings
Exhibits172: Viatris Inc. - Overview
Exhibits173: Viatris Inc. - Business segments
Exhibits174: Viatris Inc. - Key news
Exhibits175: Viatris Inc. - Key offerings
Exhibits176: Viatris Inc. - Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations